Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls

18 recalls on record · latest: April 1, 2022

Official U.S. recall history for Mylan Institutional, Inc. (d.b.a. UDL Laboratories), compiled from official government records.

Get recall alerts

Free email alert whenever Mylan Institutional, Inc. (d.b.a. UDL Laboratories) has a new recall — straight from official government data. Unsubscribe anytime.

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Cap…

April 1, 2022 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specifications: OOS result was obtained for Any O…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Cap…

April 1, 2022 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specifications: OOS result was obtained for Any O…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Alprazolam Tablets, USP, 0.25 mg, 10x10 per carton, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown,…

January 18, 2019 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specifications: Elevated levels of a known impuri…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx On…

August 14, 2018 · Drug & medication recalls Failed Impurities/Degradation Specifications; out of specification results for…

Loxapine Capsules recalled over manufacturing violations

May 1, 2018 · Drug & medication recalls Moderate risk GMP Deviations: a recent FDA inspection of the manufacturing site revealed mult…

Loxapine Capsules recalled over manufacturing violations

May 1, 2018 · Drug & medication recalls Moderate risk GMP Deviations: a recent FDA inspection of the manufacturing site revealed mult…

Atorvastatin Calcium Tablets recalled over sterility concerns

March 21, 2017 · Drug & medication recalls Moderate risk Microbial Contamination of Non-Sterile Products: potential of an elevated biobu…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown…

January 27, 2017 · Drug & medication recalls Moderate risk Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets co…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Clonazepam Tablets, USP, 1.0 mg, packaged in a 100- count unit dose box of 10 x 10 blister cards, Rx only, Manufactured…

September 28, 2016 · Drug & medication recalls Failed Impurities/Degradation Specifications: out of specification result for C…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Clonazepam Tablets, USP, 0.5 mg, packaged in a)100- count unit dose box of 10 x 10 blister cards (NDC 51079-881-20) and…

September 28, 2016 · Drug & medication recalls Failed Impurities/Degradation Specifications: out of specification result for C…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV,…

January 28, 2016 · Drug & medication recalls Failed Impurities/Degradation Specifications: out of specification result for k…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Meclizine Hydrochloride Tablets, USP, 25 mg Tablets, Packaged in 10 x 10 Tablet Blister Pack Packages, Rx Only. Manufac…

November 2, 2015 · Drug & medication recalls Failed Impurities/Degradation Specifications: Out of specification for impuriti…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100 tablets (10 X 10) per UD Cartons…

March 26, 2015 · Drug & medication recalls Failed Impurities/Degradation Specifications: the manufacturer, recalled produc…

CIPROFLOXACIN TABLETS recalled over manufacturing violations

September 26, 2013 · Drug & medication recalls Moderate risk CGMP Deviations: Pharmaceuticals were produced and distributed with active ingr…

LAMOTRIGINE TABLETS recalled over manufacturing violations

September 26, 2013 · Drug & medication recalls Moderate risk CGMP Deviations: Pharmaceuticals were produced and distributed with active ingr…

Amlodipine Besylate Tablets recalled over manufacturing violations

September 17, 2013 · Drug & medication recalls Moderate risk CGMP Deviations: Pharmaceuticals were produced and distributed with active ingr…

Amlodipine Besylate Tablets recalled over manufacturing violations

September 17, 2013 · Drug & medication recalls Moderate risk CGMP Deviations: Pharmaceuticals were produced and distributed with active ingr…

Amlodipine Besylate Tablets recalled over manufacturing violations

September 17, 2013 · Drug & medication recalls Moderate risk CGMP Deviations: Pharmaceuticals were produced and distributed with active ingr…